Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1995
03/29/1995EP0645450A1 Human calcitonin precursor polyprotein structural gene
03/29/1995EP0645397A1 Glutathione analogs and paralog panels comprising glutathione mimics
03/29/1995EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy
03/29/1995EP0645136A2 Physiologically active substance-prolonged releasing-type pharmaceutical preparation
03/29/1995EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/29/1995EP0644946A1 Vector particles resistant to inactivation by human serum
03/29/1995EP0644944A1 Adeno-associated virus with inverted terminal repeat sequences as promoter
03/29/1995EP0644939A1 Protein kinase c (iota)
03/29/1995EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644935A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
03/29/1995EP0644932A1 Purified forms of dnase
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644899A1 Production of recombinant human lactoferrin
03/29/1995EP0644898A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof
03/29/1995EP0644897A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
03/29/1995EP0644896A1 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE
03/29/1995EP0644895A1 Active component of parathyroid hypertensive factor
03/29/1995EP0644893A1 Inhibition of trauma-induced tumor growth
03/29/1995EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase
03/29/1995EP0644774A1 Improved production of reproductive hormones
03/29/1995EP0644773A1 Anti-aids immunomodulator complex
03/29/1995EP0644772A1 Opioid peptides
03/29/1995EP0644771A1 Erythropoietin drug delivery system
03/29/1995EP0644770A1 Stabilized somatotropin for parenteral administration
03/29/1995EP0644769A1 Biologically active peptides having n-terminal substitutions
03/29/1995EP0644768A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
03/29/1995EP0500602B1 Agent for neutralising the procoagulant activity associated with tumor cells
03/29/1995EP0472670B1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination
03/29/1995EP0436005B1 Labeled polypeptide derivatives
03/29/1995EP0403558B1 Antibodies for use in antilymphocyte antibody therapy
03/29/1995EP0393045B1 Fv antibody fragment production
03/29/1995EP0332667B1 Vector for integration site independent gene expression in mammalian host cells
03/29/1995CN1100656A Improved meningococcal polysaccharide conjugate vaccine
03/28/1995US5401835 Human erythroid p55 nucleic acids
03/28/1995US5401832 Brain derived and recombinant acidic fibroblast growth factor
03/28/1995US5401829 Biologically active molecules
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof
03/28/1995US5401722 Peptide analogues
03/28/1995US5401721 Antiulcer agents and antisecretory agents
03/28/1995US5401652 Nucleic acid sequence encoding apamin receptor protein
03/28/1995US5401651 DNA encoding ENA-78, a neutrophil activating factor
03/28/1995US5401650 Cloning and expression of biologically active α-galactosidase A
03/28/1995US5401648 Peptides having peptidyl transferase inhibiting activity and methods of use thereof
03/28/1995US5401638 Detection and quantification of neu related proteins in the biological fluids of humans
03/28/1995US5401510 Wound healing modulators, non-steroidal antiinflammatory agents
03/28/1995US5401509 Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation
03/28/1995US5401243 Controlled administration of chemodenervating pharmaceuticals
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/28/1995CA1334942C Production of m-csf
03/25/1995CA2132668A1 Heparin binding site structural analogues of fibroblast growth factors
03/23/1995WO1995008001A1 Dna sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007992A2 Cloned glutamic acid decarboxylase
03/23/1995WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine
03/23/1995WO1995007984A1 Human receptor h4-1bb
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007981A1 Grb3-3 gene, variants and uses thereof
03/23/1995WO1995007936A1 Dextrane esters, process for producing them and their use for encasing and encapsulating medicaments
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007933A1 Methods and composition for the modulation of host immune response to allergens
03/23/1995WO1995007932A1 Improvements in or relating to haemoglobin
03/23/1995WO1995007931A1 Acylated insulin
03/23/1995WO1995007930A1 Protein for mediating cholesterol absorption and an inhibitor thereof
03/23/1995WO1995007929A1 Multiple branch peptide constructions for use against hiv
03/23/1995WO1995007928A1 Process for purifying 1-[n2-((s)-ethoxycarbonyl)-3-phenylpropyl)-n6-trifluoroacetyl]-l-lysyl-l-proline (lisinopril(tfa)ethyl ester)
03/23/1995WO1995007924A1 Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
03/23/1995WO1995007923A1 Multi-unit ribozyme inhibition of oncogene expression
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995WO1995007914A1 Novel salts of amino glycosides
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007717A1 Method of inhibiting binding of reticulocytes to endothelium by interfering with vla-4/vcam-1 interactions
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007715A1 Cd8+ cell antiviral factor
03/23/1995WO1995007714A1 DNA SEQUENCE ENCODING HUMAN CYSTATHIONINE β-SYNTHASE
03/23/1995WO1995007713A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency
03/23/1995WO1995007712A1 Method to enhance trombomodulin apc generation using cationic proteins
03/23/1995WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide
03/23/1995WO1995007710A1 Remedy for wound
03/23/1995WO1995007709A1 Remedy for cranial nerve disorder
03/23/1995WO1995007708A2 Therapeutic use of the retinoblastoma susceptibility gene product
03/23/1995WO1995007707A1 Alteration of immune response using pan dr-binding peptides
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995007705A1 Method for inhibiting vascular leakage and anti-inflammatory compounds
03/23/1995WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
03/23/1995WO1995007689A1 Compositions containing swelling pharmaceuticals
03/23/1995WO1995007688A1 Skin care method and composition
03/23/1995WO1995007687A1 Skin care method and composition
03/23/1995WO1995007686A1 Skin care composition comprising thiol proteases from the stratum corneum
03/23/1995WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995WO1995003333A3 Tryptase inhibitor
03/23/1995WO1995003329A3 Selective amylin antagonist peptides and uses therefor
03/23/1995WO1994029469A3 Plasmids suitable for gene therapy
03/23/1995DE4332041A1 Use of pentoxifylline for the treatment of granulomatous and fibrotic pulmonary disorders
1 ... 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 ... 3163